PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-26.96%
Both companies show declining revenue. Martin Whitman would check for industry-wide issues.
-13.14%
Cost reduction while VET shows 12.62% growth. Joel Greenblatt would examine competitive advantage.
-36.13%
Both companies show declining gross profit. Martin Whitman would check industry conditions.
-12.55%
Both companies show margin pressure. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
-0.85%
G&A reduction while VET shows 1.57% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
448.00%
Other expenses growth above 1.5x VET's 100.00%. Michael Burry would check for concerning trends.
6.04%
Operating expenses growth while VET reduces costs. John Neff would investigate differences.
-2.64%
Total costs reduction while VET shows 2.55% growth. Joel Greenblatt would examine advantage.
-2.83%
Both companies reducing interest expense. Martin Whitman would check industry trends.
-5.43%
D&A reduction while VET shows 16.68% growth. Joel Greenblatt would examine efficiency.
58.42%
EBITDA growth while VET declines. John Neff would investigate advantages.
142.72%
EBITDA margin growth while VET declines. John Neff would investigate advantages.
-206.50%
Both companies show declining income. Martin Whitman would check industry conditions.
-245.82%
Both companies show margin pressure. Martin Whitman would check industry conditions.
131.19%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
30.40%
Pre-tax income growth 50-75% of VET's 46.47%. Martin Whitman would scrutinize operations.
4.70%
Pre-tax margin growth below 50% of VET's 29.29%. Michael Burry would check for structural issues.
17.53%
Tax expense growth while VET reduces burden. John Neff would investigate differences.
38.07%
Similar net income growth to VET's 39.58%. Walter Schloss would investigate industry trends.
15.21%
Similar net margin growth to VET's 20.18%. Walter Schloss would investigate industry trends.
38.02%
Similar EPS growth to VET's 40.63%. Walter Schloss would investigate industry trends.
38.57%
Similar diluted EPS growth to VET's 39.68%. Walter Schloss would investigate industry trends.
-0.10%
Share count reduction while VET shows 1.18% change. Joel Greenblatt would examine strategy.
0.81%
Diluted share change of 0.81% while VET is stable. Bruce Berkowitz would verify approach.